Tag Archives: diabetes research

Receiving a diagnosis of type 1 diabetes can feel overwhelming. Yet for many adults, the weeks or months that follow bring an unexpected twist. Blood glucose levels often become easier to control, insulin needs decrease, and some people wonder if their diabetes is actually improving. This temporary period is known …

For more than a century, insulin therapy has remained the cornerstone of treatment for type 1 diabetes. While continuous glucose monitors, insulin pumps, and automated insulin delivery systems have dramatically improved diabetes management, they still do not replace the body’s natural ability to regulate blood sugar. As a result, researchers …

Finding the right diabetes medication often involves trial and error. One patient may respond well to a GLP-1 receptor agonist, while another sees little benefit from the same treatment. As a result, clinicians frequently adjust medications before finding the most effective option. What if doctors could test a patient’s response …

Type 2 diabetes has traditionally been viewed as a disease driven by insulin resistance and declining pancreatic beta-cell function. However, researchers are now looking much deeper into the cell itself. Increasing evidence suggests that mitochondrial dysfunction in diabetes may be a key factor linking impaired energy production, chronic inflammation, oxidative …

For years, diabetes care has emphasized one simple message: exercise regularly. While that advice remains essential, researchers are now asking a more specific question. Could when you exercise be just as important as how much you exercise? Emerging evidence suggests the answer may be yes. The growing field of chronotherapy, …

When most people think about diabetes, they picture the pancreas, insulin, or blood sugar. However, researchers are increasingly asking a different question: what if another organ has been quietly influencing glucose metabolism all along? Surprisingly, the answer may be the skeleton. For decades, bone was viewed primarily as the body’s …

For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …

For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment. However, another hormone is quietly returning to the spotlight. Amylin diabetes therapy is making a comeback as researchers develop a new generation of drugs designed to improve blood glucose control and support weight management. Amylin …

For decades, diabetes treatment has centered on medications, insulin therapy, lifestyle changes, and increasingly sophisticated medical devices. But what if a completely different approach could help regulate blood sugar without adding another drug? That intriguing question is driving research into hepatic neuromodulation for diabetes, a promising field that uses focused …

For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …